Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, January 23rd:
Bio-Techne Corporation (TECH - Free Report) : This manufacturer of biotechnology reagents has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings rising 0.5% over the last 60 days.
Bio-Techne’s shares gained 9.9% over the last one month more than S&P 500’s gain of 5.6%. The company possesses a Momentum Score of A.
UnitedHealth Group Incorporated (UNH - Free Report) : This diversified health company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings rising 14.3% over the last 60 days.
UnitedHealth Group’s shares gained 10.7% over the last one month. The company possesses a Momentum Score of A.
Fibrocell Science, Inc. : This gene therapy company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 36.8% over the last 60 days.
Fibrocell Science’s shares gained 14.5% over the last one month. The company possesses a Momentum Score of B.
Boot Barn Holdings, Inc. (BOOT - Free Report) : This lifestyle retail chain operator has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings rising 13.6% over the last 60 days.
Boot Barn Holdings’ shares gained 9.1% over the last one month. The company possesses a Momentum Score of A.
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Wall Street’s Next Amazon
Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.
Click for details >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, January 23rd:
Bio-Techne Corporation (TECH - Free Report) : This manufacturer of biotechnology reagents has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings rising 0.5% over the last 60 days.
Bio-Techne’s shares gained 9.9% over the last one month more than S&P 500’s gain of 5.6%. The company possesses a Momentum Score of A.
UnitedHealth Group Incorporated (UNH - Free Report) : This diversified health company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings rising 14.3% over the last 60 days.
UnitedHealth Group’s shares gained 10.7% over the last one month. The company possesses a Momentum Score of A.
Fibrocell Science, Inc. : This gene therapy company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 36.8% over the last 60 days.
Fibrocell Science’s shares gained 14.5% over the last one month. The company possesses a Momentum Score of B.
Boot Barn Holdings, Inc. (BOOT - Free Report) : This lifestyle retail chain operator has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings rising 13.6% over the last 60 days.
Boot Barn Holdings’ shares gained 9.1% over the last one month. The company possesses a Momentum Score of A.
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Wall Street’s Next Amazon
Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.
Click for details >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on UNH - FREE
Get the latest research report on BOOT - FREE
Get the latest research report on TECH - FREE